Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
12/07/18 EFFECT Notice of Effectiveness 1
12/06/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
57
12/04/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
12/04/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2
12/03/18 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 32
12/03/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
66
12/03/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
109
11/30/18 8-K Current report filing
Related Documents
176
11/29/18 8-K Current report filing
Related Documents
6
11/27/18 8-K Current report filing
Related Documents
8